Stock Price
1.52
Daily Change
-0.03 -1.62%
Monthly
14.77%
Yearly
-47.94%
Q1 Forecast
1.33

Geron reported $-7.55M in EBITDA for its fiscal quarter ending in June of 2025.





Ebitda Change Date
Amgen USD 5.91B 2.31B Sep/2025
Bio Techne USD 95.94M 19.64M Sep/2025
Cassava Sciences USD -11.73M 33.44M Sep/2025
Cytokinetics USD -107.82M 45.51M Jun/2025
Exelixis USD 248.93M 28.02M Sep/2025
Genmab DKK 477M 101M Sep/2025
Geron USD -7.55M 8.85M Jun/2025
Gilead Sciences USD 4.03B 628M Sep/2025
Incyte USD 581.52M 358.87M Jun/2025
MacroGenics USD 21.95M 55.39M Sep/2025
Novartis USD 5.88B 290M Sep/2025